Cargando…

Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider

Glucocorticoids (prednisone) are essential in the treatment of RA and other autoimmune diseases. They are widely used, but treatment guidelines advise against. This viewpoint article explains why and suggests a way forward.

Detalles Bibliográficos
Autor principal:	Boers, Maarten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629782/ https://www.ncbi.nlm.nih.gov/pubmed/37338537 http://dx.doi.org/10.1093/rheumatology/kead309

Ejemplares similares

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

Artificial intelligence and the future of radiographic scoring in rheumatoid arthritis: a viewpoint
por: Bird, Alix, et al.
Publicado: (2022)

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2014)

Glucocorticoids and chronotherapy in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2016)

Viewpoint: how to measure comorbidities in patients with rheumatoid arthritis – clinical and academic value
por: Radner, Helga
Publicado: (2023)

Observational studies on glucocorticoids are harmful!
por: Boers, Maarten
Publicado: (2017)

Why and how to optimize glucocorticoid treatment in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2012)

Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis
por: Verhoeven, Frank, et al.
Publicado: (2016)

Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study
por: Palmowski, Andriko, et al.
Publicado: (2023)

Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities
por: Baraliakos, Xenofon, et al.
Publicado: (2019)

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
por: van Ouwerkerk, Lotte, et al.
Publicado: (2023)

Glucocorticoid management in rheumatoid arthritis: morning or night low dose?
por: Paolino, Sabrina, et al.
Publicado: (2017)

Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy
por: Aeberli, Daniel, et al.
Publicado: (2013)

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2014)

Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)

Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment
por: Cuppen, Bart V. J., et al.
Publicado: (2017)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis
por: van Oosten, Manon JM, et al.
Publicado: (2010)

In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis
por: Quax, Rogier AM, et al.
Publicado: (2012)

Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis
por: Donn, Rachelle, et al.
Publicado: (2007)

The use of glucocorticoids in rheumatoid arthritis - no 'rational' approach yet
por: Desai, Sonali P, et al.
Publicado: (2010)

Glucocorticoids in rheumatoid arthritis: current status and future studies
por: Hua, Charlotte, et al.
Publicado: (2020)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
por: Riley, Thomas R, et al.
Publicado: (2021)

Viewpoint: Could better understanding of risk factors for comorbidities pave the way towards personalized therapy in rheumatoid arthritis?
por: Majnik, Judit, et al.
Publicado: (2023)

Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis
por: ter Wee, Marieke M., et al.
Publicado: (2016)

Proper time to initiate antiosteoporotic treatment in rheumatoid arthritis with or without glucocorticoid use
por: Lee, Sang-Won
Publicado: (2014)

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review
por: van Tuyl, Lilian HD, et al.
Publicado: (2014)

Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
por: Kirkham, Jamie J, et al.
Publicado: (2013)

Has the rheumatoid arthritis (RA) core outcome set influenced the selection of study outcome measures?
por: Kirkham, Jamie, et al.
Publicado: (2013)

Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
por: Spinelli, Francesca Romana, et al.
Publicado: (2023)

Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis
por: Makrygiannakis, Dimitrios, et al.
Publicado: (2012)

292 Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis
por: Wallace, Beth, et al.
Publicado: (2022)

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids
por: Saag, Kenneth G., et al.
Publicado: (2022)

Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET
por: Verweij, Nicki, et al.
Publicado: (2022)

Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
por: Salton, Francesco, et al.
Publicado: (2023)

Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
por: Lee, Joo-Hyun, et al.
Publicado: (2014)

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial
por: Hartman, Linda, et al.
Publicado: (2018)

The Treatment of Rheumatoid Arthritis
Publicado: (1929)

Glucocorticoid-Responsive Cold Agglutinin Disease in a Patient with Rheumatoid Arthritis
por: Honne, Kyoko, et al.
Publicado: (2015)

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_p37aas0to1pf6mq79ar40etj8j